Login/Sign Up
Docekem 120-Rtu Injection 6 ml belongs to the class of 'anti-neoplastic/anti-cancer drugs', primarily used as a chemotherapy drug to treat cancers. It is effectively used in breast, lung, prostate, stomach, head/neck cancers. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues.
Docekem 120-Rtu Injection 6 ml contains Docetaxel, which belongs to the anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent, i.e., it prevents the cancer cells from rapidly dividing and spreading.
Docekem 120-Rtu Injection 6 ml will be administered by a healthcare professional. Your doctor will decide the dosage depending on your medical condition. The common side effects of Docekem 120-Rtu Injection 6 ml include pain/swelling at the injection site, headache, fatigue, dizziness, drowsiness, constipation, loss of appetite, indigestion, tearing of the eyes, nausea, vomiting, diarrhoea, insomnia (sleeplessness), fever (please inform your doctor if you have fever), muscle aches, and breathlessness. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not use or stop this medicine if the doctor did not advise you. Before starting Docekem 120-Rtu Injection 6 ml, let your doctor know if you have any allergic reactions, medical history of liver or kidney diseases, heart diseases, blood pressure problems, fits, lung disorders, weak immune system, anemia, low white blood cell count, vision problems, and are receiving chemotherapy. Docekem 120-Rtu Injection 6 ml is not indicated for use in pregnant and breastfeeding women. Docekem 120-Rtu Injection 6 ml may make you feel dizzy and drowsy, hence do not drive or operate machinery. It is not recommended to consume alcohol along with Docekem 120-Rtu Injection 6 ml. Docekem 120-Rtu Injection 6 ml is not recommended for children below two years of age.
Docekem 120-Rtu Injection 6 ml contains Docetaxel that belongs to the family of anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent and prevents cancer cells from rapidly dividing and spreading. Docetaxel may be used alone or in combination with other chemotherapy drugs to treat breast cancer that has spread to the tissues and lymph nodes (locally advanced breast cancer) and other parts (secondary breast cancer). It is also used in prostate cancer that does not respond to hormone treatment. It is further being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers.
Inform your doctor if you have any allergic reactions to Docekem 120-Rtu Injection 6 ml or other medications. Before starting Docekem 120-Rtu Injection 6 ml, let your doctor know if you have any medical history of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Docekem 120-Rtu Injection 6 ml can affect the unborn baby when used in pregnancy. It may also have harmful effects on the breastfed infant when used by a lactating mother. Hence, Docekem 120-Rtu Injection 6 ml is not indicated in pregnancy and breastfeeding women. If you are using Docekem 120-Rtu Injection 6 ml, use reliable contraception forms to prevent pregnancy during the course. Docekem 120-Rtu Injection 6 ml can make you feel dizzy and drowsy, thus affecting your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Avoid alcohol consumption while being treated with Docekem 120-Rtu Injection 6 ml. Docekem 120-Rtu Injection 6 ml is not recommended for patients younger than 18 years of age.
Drug-Drug Interaction: Docekem 120-Rtu Injection 6 ml may interact with antibiotics (itraconazole, erythromycin, rifabutin, metronidazole, tinidazole), HIV drugs (ritonavir), drugs to treat chronic alcoholism (disulfiram), opioid medicines (codeine, hydrocodone), muscle relaxants (carisoprodol, cyclobenzaprine), and anti-allergic medicines (cetirizine, diphenhydramine).
Drug-Food Interaction: Grapefruit and its juice may interact with Docekem 120-Rtu Injection 6 ml. Also, avoid alcohol consumption.
Drug-Disease Interaction: Docekem 120-Rtu Injection 6 ml should be used with caution in cases of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems.
Cancer: It is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Cancer growth can be prevented by chemotherapy (by strong antibiotics), radiation, and stem cell therapy.
Breast cancer: It is a type of cancer that develops in breast cells stimulated by a female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), in the fatty tissue, or the fibrous connective tissue within the breast. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, and a lump or swelling under the arm.
About Docekem 120-Rtu Injection 6 ml
Docekem 120-Rtu Injection 6 ml belongs to the class of 'anti-neoplastic/anti-cancer drugs', primarily used as a chemotherapy drug to treat cancers. It is effectively used in breast, lung, prostate, stomach, head/neck cancers. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues.
Docekem 120-Rtu Injection 6 ml contains Docetaxel, which belongs to the anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent, i.e., it prevents the cancer cells from rapidly dividing and spreading.
Docekem 120-Rtu Injection 6 ml will be administered by a healthcare professional. Your doctor will decide the dosage depending on your medical condition. The common side effects of Docekem 120-Rtu Injection 6 ml include pain/swelling at the injection site, headache, fatigue, dizziness, drowsiness, constipation, loss of appetite, indigestion, tearing of the eyes, nausea, vomiting, diarrhoea, insomnia (sleeplessness), fever (please inform your doctor if you have fever), muscle aches, and breathlessness. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not use or stop this medicine if the doctor did not advise you. Before starting Docekem 120-Rtu Injection 6 ml, let your doctor know if you have any allergic reactions, medical history of liver or kidney diseases, heart diseases, blood pressure problems, fits, lung disorders, weak immune system, anemia, low white blood cell count, vision problems, and are receiving chemotherapy. Docekem 120-Rtu Injection 6 ml is not indicated for use in pregnant and breastfeeding women. Docekem 120-Rtu Injection 6 ml may make you feel dizzy and drowsy, hence do not drive or operate machinery. It is not recommended to consume alcohol along with Docekem 120-Rtu Injection 6 ml. Docekem 120-Rtu Injection 6 ml is not recommended for children below two years of age.
₹20900*
₹17765*
MRP ₹20900
15% CB
₹3135 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Country of origin
Manufacturer/Marketer address
Docekem 120-Rtu Injection 6 ml contains Docetaxel, an anti-neoplastic agent. It prevents the cancer cells from rapidly dividing and spreading, thus slowing down their growth.
Docekem 120-Rtu Injection 6 ml should be used with caution and under doctor's supervision only if you have any medical history of any allergic reactions, liver or kidney diseases, non-small cell lung cancer, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions (excess fluid around lungs), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Let your doctor know if you have any other medical concerns before using Docekem 120-Rtu Injection 6 ml.
During treatment with Docekem 120-Rtu Injection 6 ml, it is essential to look for any signs of swelling (fluid retention/oedema), dizziness/fainting, difficulty in breathing, irregular heartbeat, swelling, pain and tenderness in the abdomen region, blood in stools, skin rashes, easy bleeding or bruising, sores in the mouth or throat or symptoms of infection like fever and sore throat. If you further notice any symptoms that are not manageable or unusual, please seek prompt medical attention.
It is advised to consult your doctor before undergoing any vaccination and take advice accordingly. Also, please avoid contact with people who have recently been vaccinated with the oral polio vaccine.
Docetaxel might cause serious allergic reactions and fluid retention if you had previously experienced allergic reactions with paclitaxel and cabazitaxel. These medicines contain polysorbate 80, an excipient. If you had any allergic reactions with medicines containing polysorbate 80, Docekem 120-Rtu Injection 6 ml is not recommended. Please consult your doctor for more information.
Alcohol
Unsafe
It is unsafe to consume alcohol while using Docekem 120-Rtu Injection 6 ml since it may cause increased dizziness and drowsiness. Please consult your doctor for more information.
Pregnancy
Unsafe
It is unsafe to use Docekem 120-Rtu Injection 6 ml in pregnancy and can have harmful effects on the unborn baby. Use reliable forms of contraception to prevent pregnancy while using Docekem 120-Rtu Injection 6 ml.
Breast Feeding
Unsafe
Docekem 120-Rtu Injection 6 ml is not recommended during breastfeeding since it may be unsafe for the breastfed infant. Please seek medical advice if you are a nursing mother before starting Docekem 120-Rtu Injection 6 ml.
Driving
Unsafe
Docekem 120-Rtu Injection 6 ml causes dizziness and drowsiness that may affect your ability to drive. Do not drive or operate machinery if you experience unmanageable side effects with Docekem 120-Rtu Injection 6 ml.
Liver
Caution
Please let your doctor know if you have any history of liver diseases or hepatic impairment. Before being treated with Docekem 120-Rtu Injection 6 ml, your doctor may advise you of blood tests to check your liver functioning.
Kidney
Caution
Please let your doctor know if you have any history of kidney diseases before starting Docekem 120-Rtu Injection 6 ml.
Children
Unsafe
Safety and efficacy of Docekem 120-Rtu Injection 6 ml have not been established in patients younger than 18 years.
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Uses of Docekem 120-Rtu Injection 6 ml
Medicinal Benefits
Docekem 120-Rtu Injection 6 ml contains Docetaxel that belongs to the family of anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent and prevents cancer cells from rapidly dividing and spreading. Docetaxel may be used alone or in combination with other chemotherapy drugs to treat breast cancer that has spread to the tissues and lymph nodes (locally advanced breast cancer) and other parts (secondary breast cancer). It is also used in prostate cancer that does not respond to hormone treatment. It is further being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers.
Side Effects of Docekem 120-Rtu Injection 6 ml
Directions for Use
Storage
Drug Warnings
Inform your doctor if you have any allergic reactions to Docekem 120-Rtu Injection 6 ml or other medications. Before starting Docekem 120-Rtu Injection 6 ml, let your doctor know if you have any medical history of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Docekem 120-Rtu Injection 6 ml can affect the unborn baby when used in pregnancy. It may also have harmful effects on the breastfed infant when used by a lactating mother. Hence, Docekem 120-Rtu Injection 6 ml is not indicated in pregnancy and breastfeeding women. If you are using Docekem 120-Rtu Injection 6 ml, use reliable contraception forms to prevent pregnancy during the course. Docekem 120-Rtu Injection 6 ml can make you feel dizzy and drowsy, thus affecting your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Avoid alcohol consumption while being treated with Docekem 120-Rtu Injection 6 ml. Docekem 120-Rtu Injection 6 ml is not recommended for patients younger than 18 years of age.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Cancer: It is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Cancer growth can be prevented by chemotherapy (by strong antibiotics), radiation, and stem cell therapy.
Breast cancer: It is a type of cancer that develops in breast cells stimulated by a female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), in the fatty tissue, or the fibrous connective tissue within the breast. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, and a lump or swelling under the arm.
by Others